Acrivon Therapeutics, Correlations

ACRV Stock

7.52 0.17 2.31%

The current 90-days correlation between Acrivon Therapeutics, and Bright Minds Biosciences is 0.16 (i.e., Average diversification). The correlation of Acrivon Therapeutics, is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak. If the correlation is 0, the equities are not correlated; they are entirely random.

Acrivon Therapeutics, Correlation With Market

Weak diversification

The correlation between Acrivon Therapeutics, Common and DJI is 0.33 (i.e., Weak diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Acrivon Therapeutics, Common and DJI in the same portfolio, assuming nothing else is changed.

Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Acrivon Therapeutics, Common. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.

Moving together with Acrivon Stock

0.67	MREO	Mereo BioPharma Group	Pair Corr
0.71	PIRS	Pieris Pharmaceuticals	Pair Corr
0.8	AFMD	Affimed NV	Pair Corr
0.62	STOK	Stoke Therapeutics	Pair Corr

Moving against Acrivon Stock

0.6	MNOV	MediciNova	Pair Corr
0.45	BMY	Bristol Myers Squibb Aggressive Push	Pair Corr
0.49	ACIU	AC Immune	Pair Corr

Related Correlations Analysis

	DRUG	HPQ	INTC	CVX	KO	TRV	JNJ	JPM	MSFT
DRUG		0.63	0.56	0.64	-0.8	0.81	-0.55	0.72	0.01	DRUG
HPQ	0.63		0.81	0.81	-0.64	0.65	-0.66	0.75	0.03	HPQ
INTC	0.56	0.81		0.81	-0.69	0.62	-0.81	0.65	0.22	INTC
CVX	0.64	0.81	0.81		-0.84	0.7	-0.86	0.87	-0.08	CVX
KO	-0.8	-0.64	-0.69	-0.84		-0.74	0.88	-0.86	0.09	KO
TRV	0.81	0.65	0.62	0.7	-0.74		-0.56	0.75	0.18	TRV
JNJ	-0.55	-0.66	-0.81	-0.86	0.88	-0.56		-0.75	0.04	JNJ
JPM	0.72	0.75	0.65	0.87	-0.86	0.75	-0.75		-0.13	JPM
MSFT	0.01	0.03	0.22	-0.08	0.09	0.18	0.04	-0.13		MSFT
	DRUG	HPQ	INTC	CVX	KO	TRV	JNJ	JPM	MSFT

Click cells to compare fundamentals

Check Volatility

Backtest Portfolio

Correlation Matchups

Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.

High positive correlations

JNJ	+ 0.88	KO
JPM	+ 0.87	CVX
TRV	+ 0.81	DRUG
INTC	+ 0.81	HPQ
CVX	+ 0.81	HPQ
CVX	+ 0.81	INTC

High negative correlations

JPM	- 0.86	KO
JNJ	- 0.86	CVX
KO	- 0.84	CVX
JNJ	- 0.81	INTC
KO	- 0.8	DRUG
JPM	- 0.75	JNJ

Risk-Adjusted Indicators

There is a big difference between Acrivon Stock performing well and Acrivon Therapeutics, Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Acrivon Therapeutics,'s multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.

	Mean Deviation	Jensen Alpha	Sortino Ratio	Treynor Ratio	Semi Deviation	Expected Shortfall	Potential Upside	Value @Risk	Maximum Drawdown
DRUG	49.12	28.18	2.88	(0.77)	4.62	(58.09)	9.23	(11.87)	1,471
HPQ	1.31	0.03	0.02	0.15	1.62	(1.30)	2.22	(2.63)	6.13
INTC	2.36	0.04	0.07	0.14	2.58	(2.68)	6.36	(3.50)	18.29
CVX	0.90	0.07	0.02	0.22	1.05	(0.93)	2.21	(1.79)	5.13
KO	0.68	(0.15)	0.00	(1.28)	0.00	0.00	1.11	(1.66)	4.00
TRV	1.08	0.15	0.11	0.27	1.17	(1.26)	1.93	(2.17)	11.31
JNJ	0.61	(0.10)	0.00	(0.37)	0.00	0.00	1.40	(1.42)	3.25
JPM	1.12	(0.01)	0.06	0.12	1.42	(1.19)	2.05	(2.00)	15.87
MSFT	0.90	(0.03)	(0.04)	0.07	1.49	(0.86)	2.09	(1.85)	8.19

Acrivon Therapeutics, Corporate Management

Peter MD	Chairman, CoFounder	Profile
Jesper Olsen	Head CoFounder	Profile
Dr MBA	Senior Affairs	Profile
Katharine CPA	Vice Accounting	Profile
Bruce Close	Vice Compliance	Profile
MaryAlice JD	Chief Officer	Profile
Crystal Mercado	Global HR	Profile

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC